Blue Sail Medical Co.,Ltd.

Symbol: 002382.SZ

SHZ

5.98

CNY

Market price today

  • -9.6911

    P/E Ratio

  • -0.8964

    PEG Ratio

  • 6.02B

    MRK Cap

  • 0.07%

    DIV Yield

Blue Sail Medical Co.,Ltd. (002382-SZ) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.13%

Operating Profit Margin

-0.12%

Net Profit Margin

-0.11%

Return on Assets

-0.04%

Return on Equity

-0.06%

Return on Capital Employed

-0.05%

Company general description and statistics

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO:Mr. Shuqiao Zhong
Full-time employees:7373
City:Zibo
Address:48 Yinuo Road
IPO:2010-04-02
CIK:

Blue Sail Medical Co.,Ltd. manufactures and sells health protection gloves in China and internationally. The company offers disposable medical, latex, nitrile, PVC, TPE, and household gloves that are used for medical inspection and protection, food processing, electronics industry, etc. It is also involved in the research, development, production, and sales of cardiac stents and interventional cardiac surgery related equipment products. The company was formerly known as Shandong Blue Sail Plastic & Rubber Co., Ltd. and changed its name to Blue Sail Medical Co.,Ltd. in July 2014. Blue Sail Medical Co.,Ltd. was founded in 2002 and is based in Zibo, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.128% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.119%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.112%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.036% return, is a testament to Blue Sail Medical Co.,Ltd.'s adeptness in optimizing resource deployment. Blue Sail Medical Co.,Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.061%. Furthermore, the proficiency of Blue Sail Medical Co.,Ltd. in capital utilization is underscored by a remarkable -0.049% return on capital employed.

Stock Prices

Blue Sail Medical Co.,Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $5.82, while its low point bottomed out at $5.72. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Blue Sail Medical Co.,Ltd.'s stock market.

Liquidity Ratios

Analyzing 002382.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 122.69% gauges short-term asset coverage for liabilities. The quick ratio (84.80%) assesses immediate liquidity, while the cash ratio (50.95%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio122.69%
Quick Ratio84.80%
Cash Ratio50.95%

Profitability Ratios

002382.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -12.01% underscores its earnings before tax deductions. The effective tax rate stands at 7.15%, revealing its tax efficiency. The net income per EBT, 92.88%, and the EBT per EBIT, 101.22%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -11.87%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-12.01%
Effective Tax Rate7.15%
Net Income per EBT92.88%
EBT per EBIT101.22%
EBIT per Revenue-11.87%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.23, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 538.09% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding85
Days of Inventory Outstanding91
Operating Cycle158.82
Days of Payables Outstanding41
Cash Conversion Cycle118
Receivables Turnover5.38
Payables Turnover8.84
Inventory Turnover4.01
Fixed Asset Turnover0.98
Asset Turnover0.32

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.09, and free cash flow per share, -0.83, depict cash generation on a per-share basis. The cash per share value, 2.28, showcases liquidity position. A payout ratio of -0.88 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, -0.02, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.09
Free Cash Flow per Share-0.83
Cash per Share2.28
Payout Ratio-0.88
Operating Cash Flow Sales Ratio-0.02
Free Cash Flow to Operating Cash Flow Ratio9.60
Cash Flow Coverage Ratio-0.02
Short Term Coverage Ratio-0.04
Capital Expenditure Coverage Ratio-0.12
Dividend Paid and Capex Coverage Ratio-0.07
Dividend Payout Ratio0.08

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 24.13%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.43, we discern the balance between debt and equity financing. The long-term debt to capitalization, 17.26%, and total debt to capitalization, 30.26%, ratios shed light on its capital structure. An interest coverage of -3.17 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio24.13%
Debt Equity Ratio0.43
Long Term Debt to Capitalization17.26%
Total Debt to Capitalization30.26%
Interest Coverage-3.17
Cash Flow to Debt Ratio-0.02
Company Equity Multiplier1.80

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.85, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.56, reflects the portion of profit attributed to each share. The book value per share, 9.41, represents the net asset value distributed per share, while the tangible book value per share, 4.35, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share4.85
Net Income Per Share-0.56
Book Value Per Share9.41
Tangible Book Value Per Share4.35
Shareholders Equity Per Share9.41
Interest Debt Per Share3.98
Capex Per Share-0.76

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 0.54%, indicates top-line expansion, while the gross profit growth, 20.85%, reveals profitability trends. EBIT growth, -228.95%, and operating income growth, -228.95%, offer insights into operational profitability progression. The net income growth, -52.66%, showcases bottom-line expansion, and the EPS growth, -51.35%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth0.54%
Gross Profit Growth20.85%
EBIT Growth-228.95%
Operating Income Growth-228.95%
Net Income Growth-52.66%
EPS Growth-51.35%
EPS Diluted Growth-54.05%
Weighted Average Shares Growth0.78%
Weighted Average Shares Diluted Growth-0.99%
Dividends per Share Growth735.50%
Operating Cash Flow Growth-114.74%
Free Cash Flow Growth-110.50%
10-Year Revenue Growth per Share70.79%
5-Year Revenue Growth per Share34.98%
3-Year Revenue Growth per Share-39.49%
10-Year Operating CF Growth per Share-125.19%
5-Year Operating CF Growth per Share-108.16%
3-Year Operating CF Growth per Share-101.92%
10-Year Net Income Growth per Share-660.00%
5-Year Net Income Growth per Share-219.15%
3-Year Net Income Growth per Share-131.24%
10-Year Shareholders Equity Growth per Share348.96%
5-Year Shareholders Equity Growth per Share-11.01%
3-Year Shareholders Equity Growth per Share-6.00%
10-Year Dividend per Share Growth per Share371.36%
5-Year Dividend per Share Growth per Share138.91%
3-Year Dividend per Share Growth per Share76.01%
Receivables Growth-1.06%
Inventory Growth15.03%
Asset Growth-1.51%
Book Value per Share Growth-10.21%
Debt Growth20.09%
R&D Expense Growth-17.51%
SGA Expenses Growth20.88%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 9,373,765,713.7, captures the company's total value, considering both debt and equity. Income quality, 0.13, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.03, gauges operational efficiency, while the research and development to revenue, 5.90%, highlights investment in innovation. The ratio of intangibles to total assets, 32.81%, indicates the value of non-physical assets, and capex to operating cash flow, 1062.13%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value9,373,765,713.7
Income Quality0.13
Sales General and Administrative to Revenue0.03
Research and Development to Revenue5.90%
Intangibles to Total Assets32.81%
Capex to Operating Cash Flow1062.13%
Capex to Revenue-15.71%
Capex to Depreciation-147.59%
Graham Number10.89
Return on Tangible Assets-5.41%
Graham Net Net-3.25
Working Capital-139,090,001
Tangible Asset Value4,419,576,059
Net Current Asset Value-2,315,345,427
Average Receivables902,105,011.5
Average Payables348,927,316.5
Average Inventory985,635,043
Days Sales Outstanding66
Days Payables Outstanding36
Days of Inventory On Hand89
ROIC-4.12%
ROE-0.06%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.62, and the price to book ratio, 0.62, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.10, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -7.10, and price to operating cash flows, -66.89, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.62
Price to Book Ratio0.62
Price to Sales Ratio1.10
Price Cash Flow Ratio-66.89
Price Earnings to Growth Ratio-0.90
Enterprise Value Multiple-10.74
Price Fair Value0.62
Price to Operating Cash Flow Ratio-66.89
Price to Free Cash Flows Ratio-7.10
Price to Tangible Book Ratio0.71
Enterprise Value to Sales1.90
Enterprise Value Over EBITDA86.59
EV to Operating Cash Flow-128.61
Earnings Yield-8.36%
Free Cash Flow Yield-12.46%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Blue Sail Medical Co.,Ltd. (002382.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -9.691 in 2024.

What is the ticker symbol of Blue Sail Medical Co.,Ltd. stock?

The ticker symbol of Blue Sail Medical Co.,Ltd. stock is 002382.SZ.

What is company IPO date?

IPO date of Blue Sail Medical Co.,Ltd. is 2010-04-02.

What is company current share price?

Current share price is 5.980 CNY.

What is stock market cap today?

The market cap of stock today is 6022517800.000.

What is PEG ratio in 2024?

The current -0.896 is -0.896 in 2024.

What is the number of employees in 2024?

In 2024 the company has 7373.